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Abstract
Background:  There are at least 25 human selenoproteins, each characterized by the
incorporation of selenium into the primary sequence as the amino acid selenocysteine. Since many
selenoproteins have antioxidant properties, it is plausible that inter-individual differences in
selenoprotein expression or activity could influence risk for a range of complex diseases, such as
cancer, infectious diseases as well as deleterious responses to oxidative stressors like cigarette
smoke. To capture the common genetic variants for 6 important selenoprotein genes (GPX1, GPX2,
GPX3,  GPX4,  TXNRD1, and SEPP1) known to contribute to antioxidant host defenses, a re-
sequence analysis was conducted across these genes with particular interest directed at the coding
regions, intron-exon borders and flanking untranslated regions (UTR) for each gene in an 102
individual population representative of 4 major ethnic groups found within the United States.
Results:  For 5 of the genes there was no strong evidence for selection according to the
expectations of the neutral equilibrium model of evolution; however, at the GPX1 locus (3p21)
there was evidence for positive selection. Strong confirmatory evidence for recent positive
selection at the genomic region 3p21 in Asian populations is provided by data from the
International HapMap project.
Conclusion: The SNPs and fine haplotype maps described in this report will be valuable resources
for future functional studies, for population specific genetic studies designed to comprehensively
explore the role of selenoprotein genetic variants in the etiology of various human diseases, and to
define the forces responsible for a recent selective sweep in the vicinity of the GPX1 locus.
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Background
Increasing data suggests that selenium deficiency is a risk
factor for certain cancers, neurodegenerative disorders
and complications from diabetes [1-4]. Selenium is
required for normal immune function and selenium defi-
ciency can be associated with enhanced infectious disease
severity [1,5]. Selenium deficiency impairs the expression
and production of selenium containing enzymes, known
as selenoproteins, resulting in enhanced susceptibility to
oxidative stress. In addition, it is possible that functional
polymorphisms in selenoprotein genes might also influ-
ence selenoenzyme expression, stability or activity modi-
fying disease outcomes in a manner similar to that
observed with selenium deficiency.
The 6 genes selected for re-sequencing in this project play
an important role in antioxidant defense; they include
selenoprotein P (SEPP1), thioredoxin reductase 1
(TXNRD1), and 4 selenium containing glutathione perox-
idase genes, GPX1, GPX2, GPX3 and GPX4 [6-8]. The glu-
tathione peroxidase family is the largest of the
selenoprotein gene families. Glutathione peroxidases are
named for the ability to use glutathione as a reducing sub-
strate. GPX1 and GPX2 appear to have similar substrate
specificity, catalyzing the reduction of hydrogen peroxide
to water, but differ in their tissue distribution, with GPX1
expression being particularly abundant in erythrocytes
and GPX2 expression being restricted primarily to the gas-
trointestinal tract [9,10]. GPX1 knockout mice have a nor-
mal phenotype, but are highly sensitive to oxidative
stressors[11]. Some epidemiologic studies have correlated
low GPX1 activity or particular GPX1  polymorphisms
with enhanced risk of cancer, although these correlations
have not been consistently observed in all populations
[12-17]. Mice with combined disruption of GPX1  and
GPX2 develop bacteria associated ileocolitis and intestinal
cancers [9]. GPX3 (extracellular or plasma) is a circulating
plasma selenoprotein and is able to utilize thioredoxin
reductase, thioredoxin or glutaredoxin as reductants [18].
GPX4 reduces phospholipid hydroperoxides, localizes to
the mitochondria or to the nucleus and the cytosol, and
appears to be essential for survival [19,20]. GPX4 expres-
sion is particularly high in various endocrine tissues, espe-
cially the testis. Moreover, in mature spermatozoa, GPX4
functions as a structural protein that helps anchor the
helix of mitochondria in the midpiece of spermatozoa,
suggesting a possible mechanism by which selenium defi-
ciency might impair fertility [21,22]. SEPP1 is a major
plasma selenoprotein and along with GPX3 accounts for
the majority of plasma selenium[23]. SEPP1 is a secreted
protein that likely functions as a selenium delivery mole-
cule and perhaps as an extracellular antioxidant with glu-
tathione peroxidase-like activity [24]. Unique among the
selenoproteins, SEPP1 has 10 in frame UGA codons, each
encoding for the selenium containing amino acid seleno-
cysteine [25]; the other known selenoproteins generally
have only one UGA codon [26]. Cytosolic thioredoxin
reductase (TXNRD1) is one of the most abundant sele-
nium-containing proteins and is able to catalyze the
reduction of thioredoxin in a reaction that uses electrons
from NADPH [27]. TXNRD1 is a major antioxidant redox
regulator and supports the function of p53. It's expression
may be regulated in a contrasting pattern to GPX1 in cer-
tain cancer systems and disruption of its expression may
reverse the phenotype and carcinogenicity of lung cancer
cells [28].
The primary goal of this study was to characterize genetic
variation across 6 selenoprotein genes. Specifically, re-
sequence analysis was performed in a multiethnic popu-
lation to determine common single nucleotide polymor-
phisms (SNPs) and estimate haplotypes for use in large
genetic association studies or for future functional studies.
Sequence analysis targeted exons, regulatory regions and
the sequence motifs characteristic of selenoproteins; the
latter include an in frame UGA "stop" codon that is
recoded to allow insertion of the selenium containing
amino acid selenocysteine [26]. Both cis-acting features,
including a 3' UTR RNA stem loop known as a seleno-
cysteine insertion sequence (SECIS), and trans-acting fac-
tors (including tRNA-selenocysteine (TRSP), a
selenocysteine-tRNA-specific elongation factor (EEFSEC)
and SECIS binding protein 2 (SECISBP2)) are required for
efficient selenoprotein translation [29-32]. Lastly, the
selenoprotein SNPs and fine haplotype maps described in
this report will be valuable resources for future functional
studies and for population specific genetic studies
designed to comprehensively explore the role of seleno-
protein genetic variants in the etiology of human diseases.
Results
Polymorphism analysis
Six selenoprotein genes (GPX1,  GPX2,  GPX3,  GPX4,
SEPP1  and  TXNRD1) were re-sequenced using the
SNP500 polymorphism discovery resource (Table 1), a
panel of 102 DNA samples obtained from lymphoblast-
oid cell lines from 4 ethnically diverse control groups,
Caucasian (CA, n = 31), African American (AA, n = 24),
Pacific Rim/Asian (PR, n = 24), and Hispanic (HI, n = 23).
In all, the re-sequencing project covered 58,251 base pairs
of genomic sequence, for a total of >5.9 million
sequenced base pairs. The mean number of base pairs
sequenced per gene was 9709 (range, 7007 to 13,880).
On average we sequenced 3320 bases 5' of the ATG and
3282 bases 3' of the stop codon. In each case the re-
sequencing spanned all exonic regions and the 3' UTR
SECIS region. The re-sequencing of the SEPP1 locus was
extended to include the exons and 5' region of an anti-
sense transcript that overlaps the 3' UTR of the SEPP1
locus. Of the 235 segregating sites, the number of SNPsBMC Genetics 2006, 7:56 http://www.biomedcentral.com/1471-2156/7/56
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with a rare allele frequency ≥0.05 or ≥0.1 were 103 and
92, respectively. In this regard, we observed a small
number of rare variants (Additional Files 1 to 6).
The analysis of the possible sites of heterozygosity in the
coding regions revealed several interesting observations.
Of the 235 SNPs determined across the 6 genes, our anal-
ysis identified 5 non-synonymous variants, 6 synony-
mous variants and 224 non-coding SNPs. The coding
region SNPs identified were located in the GPX1 (P75R,
L91L, A192T, and P198L), GPX3 (L13L), GPX4 (L193L),
TXNRD1 (L55L, L80L, and C383C), and SEPP1 (K19E,
A234T) loci. Since sequence variation at the RNA level
could in theory influence translation read through effi-
ciency at the UGA selenocysteine codon, synonymous var-
iants might be of particular functional relevance in
selenoproteins; however, none of the identified synony-
mous substitutions were in the immediate vicinity of a
selenocysteine codon. No putative coding region SNPs
were identified in the antisense transcript that overlaps
the 3' UTR of SEPP1. Identified non-coding SNPs
included two SECIS region SNPs, both located within the
GPX4 locus. One of these is a previously reported high fre-
quency SNP, of possible functional significance, located
44 bp from the stop codon and just before the SECIS stem
loop (stop +35 to +128) [33]. The other is a rare variant,
identified in a single individual of African American/Afri-
can heritage; this SNP (stop +103) is located in the vicinity
of the highly conserved SECIS core. SNP density varied
from 1.945 SNPs/kbp of genomic sequence in SEPP1 to
6.124 SNPs/kbp at the GPX3 locus. The mean number of
SNPs/kbp for all 6 gene loci was 4.034. Perhaps reflecting
greater functional constraint, the mean number of SNPs/
kbp was lower in coding regions at 2.161. Within the cod-
ing region, GPX1 had the most SNPs/kbp (6.568) while
GPX2 had no SNPs. Additional variation is present at the
GPX1 and SEPP1 loci in the form of a variable number
alanine repeat polymorphism within the first exon of
GPX1 and a complex variable repeat polymorphism in the
promoter of SEPP1, neither of which could be accurately
resolved from our sequence tracings [34,35].
Evolutionary analysis
We determined two measures of sequence diversity at the
6 selenoprotein loci (Table 2), the population mutation
parameter (Θ) and nucleotide diversity (π). Nucleotide
Table 1: Details of Sequence Analysis of 6 Selenoprotein Genes in a 102 Person Multi-ethnic Population Performed to Identify Single 
Nucleotide Polymorphisms
Gene Chromosome Exons Gene 
region
5'
3'
Intron
Total base 
pairs (bp) 
sequenced
Total SNPs
NSYN
SYN
SECIS Region
SNPs/kbp NSYN/kbp
SYN/kbp
SNPs/kbp Gene 
coding region
GPX1 3p21.31 2 609 3359
3431
-
7399 38
3
1
0
5.136 4.926 1.642 6.568
GPX2 14q24.1 2 570 3001
2896
2666
9133 47
0
0
0
5.146 -
-
-
GPX3 5q33.1 5 678 2930
2030
2853
8491 52
0
1
0
6.124 -
1.475
1.475
GPX4 19p13.3 7 594 2453
1783
2177
7007 31
0
1
2
4.424 -
1.684
1.684
TXNRD1 12q23.3 13 1497 5341
3320
3722
13880 43
0
3
0
3.098 -
2.004
2.004
SEPP1 5p13.1 4 1143 2833
6231
2134
12341 24
2
0
0
1.945 1.750
-
1.750
Total 33 5091 53160 58251 235
5
6
0
4.034 0.982
1.179
2.161BMC Genetics 2006, 7:56 http://www.biomedcentral.com/1471-2156/7/56
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diversity and the population mutation parameter differ in
that Θ is a measure of the number of variant sites and π is
a measure of the observed heterozygosity per base pair.
More specifically, nucleotide diversity is a parameter used
to measure the degree of polymorphism within a popula-
tion; it is defined as the average number of nucleotide dif-
ferences per site between and two DNA sequences chosen
randomly from the sample population. The population
mutation parameter differs in that it is a measure of the
observed number of variant sites, normalized to the
number of chromosomes studied and the total sequence
length, which corrects for sample size [36]. For the 6 genes
the mean value for nucleotide diversity was 7.2 × 10-4. The
greatest amount of nucleotide diversity (11.0 × 10-4) was
observed at the GPX3 locus, while the least amount of
nucleotide diversity was observed at the TXNRD1 locus
(3.7 × 10-4). In general, the value for sequence diversity as
measured by nucleotide diversity was similar to that
measured by the population mutation parameter. For the
6 genes, the mean value for the population mutation
parameter was 7.3 × 10-4. Under the infinite-sites model
of DNA sequence evolution, if the nucleotide sequence
variation among haplotypes at a locus is neutral and the
sample population is in equilibrium with respect to drift
and mutation, then the degree of polymorphism esti-
mated by calculating the nucleotide diversity and the pop-
ulation mutation parameter should be equal. This is
measured statistically using the Tajima's (DT) statistic
[37]. A strongly negative Tajima's D test is suggestive of
positive selection. In the Asian population at the GPX1
locus there was a strongly negative DT value (-1.760),
however this test did not achieve statistical significance (P
> 0.05, P < 0.10). Using an alternative neutrality test, the
DF and F statistics of Fu and Li [38], however, we do detect
possible evidence of selection at the GPX1 locus. Although
non-significant for the various subpopulations, for the
combined populations the values for DF (-2.495) and F (-
2.319) are significant at the P < 0.05 level. We also
observed significantly positive (P < 0.05) Tajima's D tests
at the GPX4 (2.249) and the SEPP1 (2.056) loci, in the
Hispanic and Caucasian populations, respectively.
Although a positive D tests might be indicative of balanc-
ing selection (positive heterozygote advantage), a very
plausible explanation for the positive tests in this case is
the presence of a significant degree of genetic admixture
within one or both of the control populations [39].
Confirmation of recent positive selection using data from 
the HapMap Project
To confirm recent positive selection at the GPX1 locus, we
used the web application Haplotter, developed in the
Pritchard laboratory, to query a map of recent positive
selection in the human genome. The input SNP data for
this map are derived from the Phase 1 International Hap-
Map Project [40]. Strong evidence for recent positive selec-
tion, as evidenced by a strong iHS (integrated haplotype
score) signal, supports the hypothesis that the GPX1 locus
has undergone a recent selective sweep in the Asian Popu-
lation (Figure 1) [41]. Strong signatures of positive selec-
tion were not observed at the GPX2,  GPX3,  GPX4,
TXNRD1 or SEPP1 loci in any of the subpopulations.
Genetic difference between sample groups
The proportion of the total genetic variance (Fst) con-
tained in a subpopulation relative to the total genetic var-
iance was calculated (Table 3). The data from the re-
sequencing of the SNP500Cancer population suggest that
there is some evidence for specific differences in genotype
distribution between different ethnic groups, especially at
the GPX1 locus. At the GPX1 locus the estimation of pop-
ulation subdivision between the Pacific Rim/Asian and
the African American/African populations was 0.2418,
and between the Pacific Rim/Asian and the Caucasian
populations it was 0.2682. Altogether, these data suggest
that there is evidence for specific differences in genotype
distribution between the different ethnic groups, espe-
cially at the GPX1 locus.
Haplotype structure
The most probable PHASED haplotypes derived using
SNPs with minimum rare allele frequencies of ≥5% are
presented as supplementary data (Additional Files 7 to
12). Estimates for linkage disequilibrium (LD) and loca-
tion of major haplotype blocks across each of the 6
selenoprotein loci are provided for the total population in
Figures 2 to 7 and for each of the individual ethnic groups
in the supplementary data files (Additional File 13). For
the data set, the haplotype diversity is restricted and the
number of unique haplotypes varied by gene locus from
16 (GPX1) to 51 (GPX3), with a mean of 28.2. In most
cases, the African American population had the greatest
number of unique haplotypes (mean 14.8), whereas the
Pacific Rim/Asian population had the fewest (mean 9.2).
The number of common haplotypes with a frequency of
≥0.05 ranged from 3 (GPX3) to 5 (GPX1,  SEPP1  and
TXNRD1). Examined in a population specific manner, we
also noted variation in the frequency of these major hap-
lotypes. At the GPX1  locus, for example, haplotype
number 1 was observed in 63% of individuals of Pacific
Rim/Asian heritage, whereas the frequency of this major
haplotype was much lower in the other populations (AA
0.17, CA 0.13 and HI 0.30). Similarly, at the TXNRD1
locus haplotype 1 had a frequency of 65% in the Pacific
Rim/Asian population, but was observed less often in the
other populations (AA 0.29, CA 0.19, and HI 0.28).
Although the functional significance of the various
imputed haplotypes remains to be determined, it is of
interest to note that key SNPs of possible functional con-
sequences segregate with particular haplotypes. For exam-
ple, the T variant of a common GPX4 SECIS region SNPBMC Genetics 2006, 7:56 http://www.biomedcentral.com/1471-2156/7/56
Page 5 of 20
(page number not for citation purposes)
Table 2: Sequence Diversity and Evolutionary Analysis of 6 Selenoprotein Loci Stratified by Estimated Population
Gene Ethnic Group SNPs Singletons SYN NSYN π × 10-4 Θ × 10-4 DT Tajima's DF F
GPX1
202 Total 38 14 1 3 5.2 8.7 -1.16256 -2.49532* -2.31912*
48 AA 23 6 1 3 6.5 7.0 -0.25380 -0.23160 -0.28398
62 CA 15 3 0 2 5.3 4.3 0.69670 0.119874 0.38011
46 HI 20 10 0 2 5.1 6.2 -0.55642 -1.92897** -1.72989
46 PR 15 6 0 2 2.0 4.7 -1.75961** -1.12837 -1.58364
GPX2
204 Total 47 11 0 0 8.2 8.7 -0.18534 -0.85302 -0.67535
48 AA 27 7 8.1 6.7 0.69919 -0.22648 0.11635
62 CA 33 7 6.7 7.7 -0.43521 0.03790 -0.16317
46 HI 32 8 8.7 8.0 0.31148 -0.13732 0.02421
48 PR 30 8 6.6 7.4 -0.36659 -0.28952 -0.37648
GPX3
204 Total 52 6 1 0 11.0 10.4 0.18669 0.76044 0.60998
48 AA 42 4 1 13.9 11.1 0.84504 1.12623 1.22113
62 CA 30 2 0 8.6 7.5 0.47394 1.29418 1.18465
46 HI 38 8 1 10.1 10.2 -0.03486 0.17869 0.12254
48 PR 37 10 1 9.5 9.8 -0.11667 -0.32911 -0.30155
GPX4
204 Total 31 7 1 0 10.4 7.7 0.99362 -0.65746 0.03750
48 AA 24 6 0 9.9 7.9 0.85392 -0.15103 0.23582
62 CA 21 3 0 10.2 6.5 1.77252** 0.57981 1.19930
46 HI 18 3 0 10.2 6.0 2.24912* 0.46442 1.26672
48 PR 19 3 1 10.0 6.3 1.88377** 0.53274 1.17584
TXNRD1
204 Total 43 10 3 0 3.7 5.2 -0.84233 -0.81317 -0.99372
48 AA 28 5 2 4.4 4.5 -0.09852 0.40341 0.26989
62 CA 22 3 1 3.8 3.4 0.44241 0.64623 0.68209
46 HI 24 7 1 3.9 3.9 -0.02622 -0.44254 -0.35427
48 PR 20 7 2 2.3 3.2 -0.96694 -0.87634 -1.07578
SEPP1
204 Total 24 5 0 2 4.8 3.3 1.25024 -0.41307 0.31238
48 AA 17 3 1 3.8 3.1 0.73630 0.37764 0.59147
62 CA 18 2 1 5.2 3.1 2.05607* 0.80818 1.48364**
46 HI 17 2 2 5.0 3.1 1.83966** 0.79897 1.36158
48 PR 16 0 1 4.5 2.9 1.66728 1.59572* 1.91681*
Single nucleotide polymorphisms (SNPs) were identified by re-sequencing 6 selenoprotein gene regions in a 102 member control population. 
Nucleotide diversity (π) and the population mutation parameter (Θ) were calculated using the most probable PHASED haplotypes. To determine 
whether variation was consistent with the expectations of the neutral equilibrium model, neutrality was tested using Tajima's (DT) and Fu and Li's 
(DF and F) statistics. DT, DF and F were computed using S, the number of segregating sites, in DNASP.
*Statistical significance: P < 0.05
**Statistical significance: P < 0.10, P > 0.05BMC Genetics 2006, 7:56 http://www.biomedcentral.com/1471-2156/7/56
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(Stop +44) is found in haplotype 1 but not in any of the 8
next most common GPX4 haplotypes. Similarly, for the
GPX1 P198L variant, the proline variant (C) resides on the
4 most common GPX1 haplotypes whereas the lucine var-
iant (T) is only observed on the backbone of several rarer
haplotypes (5, 6, 9, 10, 13, and 14); these rarer haplotypes
are relatively uncommon among individuals of Pacific
Rim/Asian heritage. In addition, there is a common non-
synonymous (A234T) variant in SEPP1, located between 2
histidine rich regions. This variant is a major distinguish-
ing feature between the most common SEPP1 haplotype
(0.36) and the next most common haplotype (0.18).
Again it is notable that the T234 encoding haplotypes (2,
6 and 10) are rare in the Asian/Pacific Rim Populations,
with respective frequencies of only 0.04, 0.02 and 0.
Discussion
Selenium deficiency impairs the production of selenium
containing proteins and may be a risk factor for cancer,
infectious disease severity and enhanced susceptibility to
oxidant stressors. Recently, selenium has emerged as one
of the most promising cancer chemoprevention agents
and is the focus of a large clinical trial (SELECT) that has
enrolled 35,000 men to determine if selenium supple-
mentation prevents prostate cancer[3,4,42]. It is possible
that the anticancer properties of selenium are mediated
through selenoproteins, many of which have antioxidant
properties. An alternative hypothesis, however, suggests
that the anticancer property of selenium compounds
occurs at doses beyond those that are required to ensure
maximal selenoprotein production [43,44]. If selenopro-
teins play a direct role in cancer chemoprevention, then it
is possible that genetic variation in selenoprotein activity
or expression might also modify susceptibility to genome
damaging environmental exposures such as cigarette
smoke or dietary carcinogens. Similarly, it is also possible
that inter-individual variation in selenoprotein expression
could modify disease outcomes by influencing major anti-
Confirmation of recent positive selection at the GPX1 locus (3p21) Figure 1
Confirmation of recent positive selection at the GPX1 locus (3p21). To confirm recent positive selection at the GPX1 
locus, we used Haplotter to query the results of a scan for positive selection in the human genome developed using SNP data 
from the International HapMap project [41]. The vertical line indicates the location of the GPX1 locus. The strong iHS (inte-
grated haplotype score) signal in the Asian (ASN) population at this locus is highly suggestive for recent positive selection. Data 
is based on the analysis of unrelated individuals from 3 populations: ASN (Han Chinese and Japanese, n = 89), CEU (Northern 
and Western European, n = 60), and YRI (Sub-Saharan Africans from the Yoruban population, n = 60).BMC Genetics 2006, 7:56 http://www.biomedcentral.com/1471-2156/7/56
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oxidant pathways, such as the glutathione cycle or thiore-
doxin metabolism. Pathways relevant not only to cancer
susceptibility, but also to chemotherapy induced toxicities
[45], and infectious disease severity (i.e., viral myocardi-
tis, malaria, and septic shock syndrome) [46-48]. We
therefore explored the genetic variation in 6 selenoprotein
genes in order to provide the foundation for the compre-
hensive analysis of selenoprotein genetic variation in can-
didate gene association studies. In this regard we have re-
sequenced 6 of the 25 known human selenoprotein genes
to identify common SNPs and haplotypes and to explore
the selective processes acting on these loci. The genes
selected for re-sequencing and evolutionary analysis are
among the best-studied selenoproteins and all have
important antioxidant properties; they include 4 glutath-
ione peroxidases (GPX1-4), SEPP1 and TXNRD1 [6-8].
In total, we sequenced approximately 5.9 million base
pairs of DNA from 102 individuals, representative of 4
ethnic populations common within the United States,
Caucasian (CA, n = 31), African American (AA, n = 24),
Pacific Rim/Asian (PR, n = 24), and Hispanic (HI, n = 23).
We identified 235 SNPs, of which 103 had a rare allele fre-
quency of greater than 0.05. For the 6 selenoprotein genes
the mean value for nucleotide diversity was 7.2 × 10-4,
which is similar to the value of 6.7 × 10-4 obtained by the
Environmental Genome Project which recently re-
sequenced 213 genes in 90 individuals[49]. Particularly
interesting SNPs (with minimum rare allele frequency
≥0.05), of potential functional importance, include the
GPX1 P75R and P198L variants, a high frequency GPX4
SECIS region SNP, and an A234T non-synonymous vari-
ant in SEPP1. The GPX1 P198L and GPX4 SECIS SNPs
have both been previously described [16,33]. In addition,
we identified a rare GPX4  SECIS SNP adjacent to the
SECIS core. SECIS SNPs are of particular interest, as this
RNA stem loop structure is required for the translational
incorporation of the amino acid selenocysteine. In the
absence of a functional SECIS, translation will terminate
prematurely at the UGA-selenocysteine codon. At this
point, the functional significance of the identified SNPs
and haplotypes remains largely uncharacterized.
Although there is data suggesting that each GPX1-L198
allele decreases red cell glutathione peroxidase activity by
about 5%, attempts to correlate enzyme activities with
specific genotypes have provided inconsistent results, per-
haps reflective of the observation that selenium status
may influence selenoprotein expression or enzymatic
Table 3: Estimation of Population Subdivision (Fst) at 6 Selenoprotein Loci
GPX1 HI AA PR
AA 0.0718
PR 0.0882 0.2418
CA 0.0441 0.0631 0.2682
GPX2 HI AA PR
AA 0.0825
PR 0.0739 0.1347
CA 0.0178 0.2105 0.1127
GPX3 HI AA PR
AA 0.0667
PR 0.0388 0.1553
CA 0.0048 0.1273 0.0318
GPX4 HI AA PR
AA 0.0761
PR -0.0100 0.0535
CA -0.0175 0.0915 -0.0038
SEPP1 HI AA PR
AA 0.0589
PR -0.0110 0.1023
CA -0.0104 0.0649 0.0096
TXNRD1 HI AA PR
AA -0.0078
PR 0.0801 0.1088
CA -0.0137 0.0066 0.0836
All 6 Genes HI AA PR
AA 0.0610
PR 0.0381 0.1290
CA 0.0022 0.1057 0.0684
Fst was calculated by pairwise comparison of all subpopulations. A high Fst implies a considerable degree of differentiation among populations. The 
negative Fst values noted in some cells should be interpreted that there is no genetic differentiation between the two population and likely reflects 
the imprecision of the algorithm used by the software to estimate this value.BMC Genetics 2006, 7:56 http://www.biomedcentral.com/1471-2156/7/56
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Estimates for linkage disequilibrium (LD) and location of major haplotype blocks across 6 selenoprotein loci Figure 2
Estimates for linkage disequilibrium (LD) and location of major haplotype blocks across 6 selenoprotein loci. 
Pair wise plots (D') across 6 selenoprotein loci based on genotype data obtained from re-sequencing the 102 person multieth-
nic SNP500 DNA population, which is comprised of individuals of AA, CA, HI and PR heritage. LD plots for the various ethnic 
subpopulations are available as supplementary data. Re-sequenced genes include GPX1 (Figure 2), GPX2 (Figure 3), GPX3 
(Figure 4), GPX4 (Figure 5), SEPP1 (Figure 6), and TXNRD1 (Figure 7). SNP identifiers are indicated on the abscissas. Num-
bers within cells correspond to LD values (D'). The LD color scheme is stratified according to the logarithm of the odds (LOD) 
score and D': LOD <2 (white for D'<1 and blue for D' = 1) or LOD >2 (shades of pink/red for D'<1 and bright red for D' = 1). 
Haplotype blocks were created using the algorithm of Gabriel et al, Science 2002 [76]. 95% confidence bounds on D' were gen-
erated and each comparison was called "strong LD", "inconclusive" or "strong recombination". A block was created if 95% of 
informative comparisons were "strong LD".BMC Genetics 2006, 7:56 http://www.biomedcentral.com/1471-2156/7/56
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activity[16,33,50]. Moreover, it is possible that haplotype
analysis may provide a better means for correlating enzy-
matic activity or serum selenium levels, especially if this is
done in individuals maintained on a diet containing opti-
mal supplemental selenium.
Overall the pattern of the observed genetic variation was
consistent with the expectations of the neutral equilib-
rium model of evolution for 5 genes, but at the GPX1
locus we found evidence for selection. At the GPX1 locus,
the DF and F statistics of Fu and Li were strongly negative.
The presence of a significantly negative D value indicates
the presence of an excess of rare alleles inconsistent with
neutral processes in a stable population, but consistent
with either a demographic or selective processes [38]. The
fact that a similar phenomenon is not observed at the
other loci, suggests that the phenomenon is not simply
the result of a demographic process such as a recent pop-
ulation expansion. Additional support for selection at the
GPX1  locus is provided by the negative value for the
Tajima's test (-1.760) in the Pacific Rim/Asian popula-
tion, which just missed achieving statistical significance (P
> 0.05, P < 0.10). Of further interest, we also found evi-
dence for differences in genotype distribution between
different ethnic groups, especially at the GPX1 locus. The
relatively high Fst values of 0.2418 (Pacific Rim/Asian vs.
African American/African) and of 0.2682 (Pacific Rim/
Asian vs. Caucasian) suggest that there is substantial
Estimates for linkage disequilibrium (LD) and location of major haplotype blocks across 6 selenoprotein loci Figure 3
Estimates for linkage disequilibrium (LD) and location of major haplotype blocks across 6 selenoprotein loci. 
Pair wise plots (D') across 6 selenoprotein loci based on genotype data obtained from re-sequencing the 102 person multieth-
nic SNP500 DNA population, which is comprised of individuals of AA, CA, HI and PR heritage. LD plots for the various ethnic 
subpopulations are available as supplementary data. Re-sequenced genes include GPX1 (Figure 2), GPX2 (Figure 3), GPX3 
(Figure 4), GPX4 (Figure 5), SEPP1 (Figure 6), and TXNRD1 (Figure 7). SNP identifiers are indicated on the abscissas. Num-
bers within cells correspond to LD values (D'). The LD color scheme is stratified according to the logarithm of the odds (LOD) 
score and D': LOD <2 (white for D'<1 and blue for D' = 1) or LOD >2 (shades of pink/red for D'<1 and bright red for D' = 1). 
Haplotype blocks were created using the algorithm of Gabriel et al, Science 2002 [76]. 95% confidence bounds on D' were gen-
erated and each comparison was called "strong LD", "inconclusive" or "strong recombination". A block was created if 95% of 
informative comparisons were "strong LD".BMC Genetics 2006, 7:56 http://www.biomedcentral.com/1471-2156/7/56
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genetic differentiation between these populations. Inspec-
tion of the major GPX1 haplotypes in the Pacific Rim/
Asian population reveals that the P198 containing haplo-
types predominate and that the L198 variant is rarely
observed. Moreover, this is consistent with reports that
the L198 variant was not observed among individuals of
Chinese heritage [51].
Whether the relative absence of L198 haplotypes within
the Asian population is the result of a recent selective
sweep, perhaps in response to an environmental or infec-
tious exposure, cannot be determined from our data set.
However, strong confirmation for a recent selective sweep
involving chromosome region 3p21, which includes the
GPX1 locus, is provided by analysis of SNP data from the
International HapMap project [40,41]. The strong iHS sig-
nal observed in the Asian population at this locus is one
of the highest observed on Chromosome 3 and is highly
suggestive for recent positive selection (Figure 1) [41]. A
selective sweep at the GPX1 locus may explain an earlier
observation that there is significantly less variation in red
cell glutathione peroxidase activity among individuals of
Asian heritage compared to what is observed in Occiden-
tal Populations [52]. Understanding whether functional
variants of GPX1, or other genes at the 3p21 locus, confer
protection or susceptibility in disease populations may
provide insight into the selective pressures responsible for
this recent selective sweep.
The genomic locations of several selenoprotein genes are
of particular interest. For example, there is strong LD
between the GPX1  P198L variant and variants in the
Estimates for linkage disequilibrium (LD) and location of major haplotype blocks across 6 selenoprotein loci Figure 4
Estimates for linkage disequilibrium (LD) and location of major haplotype blocks across 6 selenoprotein loci. 
Pair wise plots (D') across 6 selenoprotein loci based on genotype data obtained from re-sequencing the 102 person multieth-
nic SNP500 DNA population, which is comprised of individuals of AA, CA, HI and PR heritage. LD plots for the various ethnic 
subpopulations are available as supplementary data. Re-sequenced genes include GPX1 (Figure 2), GPX2 (Figure 3), GPX3 
(Figure 4), GPX4 (Figure 5), SEPP1 (Figure 6), and TXNRD1 (Figure 7). SNP identifiers are indicated on the abscissas. Num-
bers within cells correspond to LD values (D'). The LD color scheme is stratified according to the logarithm of the odds (LOD) 
score and D': LOD <2 (white for D'<1 and blue for D' = 1) or LOD >2 (shades of pink/red for D'<1 and bright red for D' = 1). 
Haplotype blocks were created using the algorithm of Gabriel et al, Science 2002 [76]. 95% confidence bounds on D' were gen-
erated and each comparison was called "strong LD", "inconclusive" or "strong recombination". A block was created if 95% of 
informative comparisons were "strong LD".BMC Genetics 2006, 7:56 http://www.biomedcentral.com/1471-2156/7/56
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nearby gene RHOA. Since RHOA belongs to the ras onco-
gene family and studies both in vitro and in vivo suggest
that its overexpression may lead to cancer [53,54], it is
possible that observed associations between the L198 var-
iant and an increased risk of cancer may in fact be due to
LD between this variant and as yet unidentified variants
within RHOA or another nearby gene [51]. Similarly, it is
of great interest that the 3p21 genomic region also
includes the gene for α-dystroglycan (DAG1), which
encodes for a peripheral membrane protein used as a cel-
lular receptor for arenaviruses, the causative agents of fatal
hemorrhagic fevers, and also as the Schwann cell receptor
for M. leprae [55,56]. Likewise, it is also worth noting that
SEPP1 is located at chromosome position 5p13.1, close to
chromosomal regions that contain the growth hormone
receptor and alpha-methylacyl-CoAracemase, genes of
potential relevance to cancer susceptibility [57,58]. We
also note here the presence of an antisense transcript that
overlaps the 3' UTR of SEPP1. Since some antisense tran-
scripts post-transcriptionally regulate the expression of
the overlapping transcript, we extended our resequencing
at the SEPP1  locus to include the antisense transcript.
Estimates for linkage disequilibrium (LD) and location of major haplotype blocks across 6 selenoprotein loci Figure 5
Estimates for linkage disequilibrium (LD) and location of major haplotype blocks across 6 selenoprotein loci. 
Pair wise plots (D') across 6 selenoprotein loci based on genotype data obtained from re-sequencing the 102 person multieth-
nic SNP500 DNA population, which is comprised of individuals of AA, CA, HI and PR heritage. LD plots for the various ethnic 
subpopulations are available as supplementary data. Re-sequenced genes include GPX1 (Figure 2), GPX2 (Figure 3), GPX3 
(Figure 4), GPX4 (Figure 5), SEPP1 (Figure 6), and TXNRD1 (Figure 7). SNP identifiers are indicated on the abscissas. Num-
bers within cells correspond to LD values (D'). The LD color scheme is stratified according to the logarithm of the odds (LOD) 
score and D': LOD <2 (white for D'<1 and blue for D' = 1) or LOD >2 (shades of pink/red for D'<1 and bright red for D' = 1). 
Haplotype blocks were created using the algorithm of Gabriel et al, Science 2002 [76]. 95% confidence bounds on D' were gen-
erated and each comparison was called "strong LD", "inconclusive" or "strong recombination". A block was created if 95% of 
informative comparisons were "strong LD".BMC Genetics 2006, 7:56 http://www.biomedcentral.com/1471-2156/7/56
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Future studies utilizing these data will be able to explore
if this antisense transcript plays a role in the regulation of
SEPP1.
Conclusion
Genetic variation across selenoprotein genes could be of
great interest to not only association testing strategies but
also to strategies to investigate the pattern of molecular
evolution in a group of genes with a distinctive feature,
the incorporation of the amino acid selenocysteine. The 6
genes re-sequenced in this project include some of the
best characterized selenoproteins, most of which have
important antioxidant properties. It is likely that addi-
tional selenoproteins also play a role in pathways relevant
to cancer and disease susceptibility, such as endoplasmic
reticulum stress response and inflammation [59,60]. The
potential importance of selenoproteins in a wide array of
human diseases including cancer, heart disease, aging and
infections coupled with the promise of selenium as a che-
moprevention agent warrants further investigation of the
Estimates for linkage disequilibrium (LD) and location of major haplotype blocks across 6 selenoprotein loci Figure 6
Estimates for linkage disequilibrium (LD) and location of major haplotype blocks across 6 selenoprotein loci. 
Pair wise plots (D') across 6 selenoprotein loci based on genotype data obtained from re-sequencing the 102 person multieth-
nic SNP500 DNA population, which is comprised of individuals of AA, CA, HI and PR heritage. LD plots for the various ethnic 
subpopulations are available as supplementary data. Re-sequenced genes include GPX1 (Figure 2), GPX2 (Figure 3), GPX3 
(Figure 4), GPX4 (Figure 5), SEPP1 (Figure 6), and TXNRD1 (Figure 7). SNP identifiers are indicated on the abscissas. Num-
bers within cells correspond to LD values (D'). The LD color scheme is stratified according to the logarithm of the odds (LOD) 
score and D': LOD <2 (white for D'<1 and blue for D' = 1) or LOD >2 (shades of pink/red for D'<1 and bright red for D' = 1). 
Haplotype blocks were created using the algorithm of Gabriel et al, Science 2002 [76]. 95% confidence bounds on D' were gen-
erated and each comparison was called "strong LD", "inconclusive" or "strong recombination". A block was created if 95% of 
informative comparisons were "strong LD".BMC Genetics 2006, 7:56 http://www.biomedcentral.com/1471-2156/7/56
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role of these and other selenoproteins in human disease.
We believe that the study of selenoproteins provides a
unique model system for exploring the complex interac-
tion between genes and environmental exposures. The
fine haplotype maps described in this report will be useful
for exploring associations between selenoprotein variants
and diseases, studying selenoprotein loss of heterozygos-
ity in tumor samples, or for correlating selenoprotein gen-
otypes with serum selenium levels or selenoenzyme
activity in patients enrolled on clinical trials using sele-
nium as a chemoprevention agent[61].
Methods
Population
The control population used for re-sequencing is the
SNP500Cancer DNA panel, which represents a subset of
the available DNA Polymorphism Discovery Resource
[62]. The SNP500Cancer set consists of DNAs from 102
Estimates for linkage disequilibrium (LD) and location of major haplotype blocks across 6 selenoprotein loci Figure 7
Estimates for linkage disequilibrium (LD) and location of major haplotype blocks across 6 selenoprotein loci. 
Pair wise plots (D') across 6 selenoprotein loci based on genotype data obtained from re-sequencing the 102 person multieth-
nic SNP500 DNA population, which is comprised of individuals of AA, CA, HI and PR heritage. LD plots for the various ethnic 
subpopulations are available as supplementary data. Re-sequenced genes include GPX1 (Figure 2), GPX2 (Figure 3), GPX3 
(Figure 4), GPX4 (Figure 5), SEPP1 (Figure 6), and TXNRD1 (Figure 7). SNP identifiers are indicated on the abscissas. Num-
bers within cells correspond to LD values (D'). The LD color scheme is stratified according to the logarithm of the odds (LOD) 
score and D': LOD <2 (white for D'<1 and blue for D' = 1) or LOD >2 (shades of pink/red for D'<1 and bright red for D' = 1). 
Haplotype blocks were created using the algorithm of Gabriel et al, Science 2002 [76]. 95% confidence bounds on D' were gen-
erated and each comparison was called "strong LD", "inconclusive" or "strong recombination". A block was created if 95% of 
informative comparisons were "strong LD".BMC Genetics 2006, 7:56 http://www.biomedcentral.com/1471-2156/7/56
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lymphoblastoid cell lines from 4 ethnically diverse
groups, 31 Caucasian-Americans (CA), 24 African/Afri-
can-Americans (AA), 24 Pacific Rim/Asian-Americans
(PR), and 23 Hispanic-Americans (HI). The use of these
publicly available panels, which are anonymized except
for information about ethnic group and gender, for re-
sequencing was deemed exempt from Institutional
Review Board (IRB) approval by the Johns Hopkins Uni-
versity IRB. Genotype data and validated assays for geno-
typing select haplotype tagged SNPs identified through
this re-sequencing project and for additional unrelated
loci are publicly available as part of the cancer genome
anatomy project at the SNP500 website [63].
PCR primers and sequencing
For each selenoprotein gene the full coding sequence and
approximately 3000 bases of the 5' promoter and 3' UTR
were re-sequenced. Overlapping PCR products of approx-
imately 500 bases were designed using Primer 3 (Addi-
tional File 14)[64]. Each forward primer was tagged with
a universal M13 forward sequence (5'-TGTAAAACGACG-
GCCAGT-3') and each reverse primer was tagged with a
universal M13 reverse sequence (5'-CAGGAAACAGCTAT-
GACC). The reliability of the sequencing data was ensured
by sequencing in both directions, and in the case of most
high frequency SNPs results were further confirmed by an
independent genotype methods performed through the
SNP500 genotyping project [63]. Primers were designed
to include all exons, intron/exon borders, the 5' UTR and
the 3' UTR, including SECIS elements. For some small
regions, we were unable to obtain good quality sequence,
despite multiple attempts at primer redesign and optimi-
zation. PCR and DNA sequencing reactions were ampli-
fied on MJ Research Tetrad thermalcyclers. Big Dye
Terminator chemistry sequencing reactions were run in
either 96 well or 384 well format on ABI 3700 capillary
automatic sequencers. Forward and reverse sequence trac-
ing were aligned in Sequencher 4.2 (Gene Codes, Ann
Arbor, MI) and SNPs were determined by visual inspec-
tion. SNP data was placed in "prettybase" format and
summary statistics and Hardy-Weinberg Equilibrium cal-
culations were performed using software available
through the Innate Immunity PGA [65]. Prettybase files,
the reference sequences used to assign prettybase SNP
locations, and gaps in sequence coverage are available as
supplementary data for each gene (Additional Files 15,
16, 17, 18, 19, 20, 21).
Mapping DATA
For the purpose of mapping SNPs and primer locations
we used the May 2004 assembly of the human genome
(Build 43, NCBI). Genomic sequences between the most
5' forward PCR primer and the most 3' reverse PCR primer
were obtained using the UCSC In-Silico PCR program
[66]. The location of each SNP was mapped onto the gene
structure relative to the following Entrez RefSeq curated
mRNA sequences (Additional Files 22, 23, 24, 25, 26, 27):
GPX1  (NM_000581),  GPX2  (NM_002083),  GPX3
(NM_002084),  GPX4  (NM_002085),  TXNRD1
(NM_003330), and SEPP1 (NM_005410). SNPs 5' of the
ATG are represented as a negative number relative to the
first base of the start codon; SNP 3' of the stop are repre-
sented as a positive number relative to the last base of the
stop codon; SNPs within an intron are represented as
intron number plus the number of bases from the first
base of the start of the intron; SNPs within an exon are
represented as either synonymous (SYN) or non-synony-
mous (NSYN) and the amino acid position is provided. In
the case of GPX1, the resequencing in the 5' direction
extended into the coding region of a neighboring gene, ras
homolog gene family member A (RHOA). Of note, there
is an uncharacterized phylogenetically conserved tran-
script (BC039102) overlapping the 3' end of SEPP1 in an
antisense orientation. Resequencing at the SEPP1 locus
was expanded to include putative exons and the promoter
region corresponding to this antisense transcript because
of the possibility that overlapping transcripts might post-
transcriptionally regulate each other's expression [67,68].
TXNRD1 exhibits alternative splicing at the 5' end. Our re-
sequencing corresponded to the exons of TXNRD1 tran-
script variant 1 (NM_003330) and also included the pub-
lished promoter region, which is conserved between the
mouse and human[69].
Evolutionary analysis
To compare the sequence diversity between genes, the het-
erozygosity per nucleotide site was estimated by calculat-
ing nucleotide diversity (π) and the population mutation
parameter (Θ) [70]. To determine whether the observed
variation was consistent with the expectations of the neu-
tral equilibrium model of evolution, neutrality was tested
using Tajima's (DT) and Fu and Li's (DF and F) statistics
[37,38]. The most probable imputed PHASED haplotypes
were used as input sequence for evolutionary analyses in
the software program DNASP [71]. PHASED haplotypes
were estimated using the Bayesian statistical method in
PHASE2.0 run either locally or off the Innate Immunity
web site [65,72]. PHASE output was transformed into the
proper DNASP input format using the perl script phase-
todnasp-v2.1.pl written and kindly provided by Eduardo
Tarazona Santos (Section of Genomic Variation, Pediatric
Oncology Branch, NCI, NIH, Bethesda, MD). Genomic
regions for which sequence data was not available were
excluded from various population genetic analyses (Addi-
tional File 21). Evidence for specific differences in geno-
type distribution between the various ethnic groups was
explored by calculating the allele identity F-statistic (FST)
for all population pairs using GENEPOP on the Web,
developed from the Genepop DOS versions 3.3/3.4[73].
FST is the proportion of the total genetic variance con-BMC Genetics 2006, 7:56 http://www.biomedcentral.com/1471-2156/7/56
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tained in a subpopulation (s) relative to the total genetic
variance (t). Values can range from 0 to 1. High FST
implies a considerable degree of differentiation among
populations. GENEPOP is a population genetics software
package originally designed by Michel Raymond and
Francois Rousset, at the Laboratiore de Genetique et Envi-
ronment, Montpellier, France. Transformation of data
from prettybase format to GENEPOP format was facili-
tated by using the perl script report_prettybase.pl written
by Fares Z. Najar (revised by James D. White) at the
Advanced Center for Genome Technology, University of
Oklahoma. To confirm recent positive selection at the
GPX1 locus, we used Haplotter to query the results of a
scan for positive selection in the human genome devel-
oped using SNP data from the International HapMap
project [40,41,74]. The iHS is a new test for detecting
recent positive selection developed by the Pritchard labo-
ratory and based on the extended haplotype homozygos-
ity (EHH) statistic proposed by Sabeti et al [75].
Haplotype structure and patterns of Linkage 
Disequilibrium (LD)
For each gene the most probable PHASED haplotype was
determined, as described above, using only those SNPs
that had a minimum rare allele frequency of ≥0.05. Using
the Chimp BLAT Search at the UCSC Genome Bioinfor-
matics Site, we aligned the human locus of interest and
the corresponding locus from the chimp genome (Nov.
2003 assembly) to infer a chimp haplotype [66]. LD (D')
between pairs of variants (minimum rare allele frequency
of ≥0.05) was computed using the software program Hap-
loview 3.2, using the most probable PHASED haplotypes
as the input sequence. Using Haploview, haplotype
blocks were created using the algorithm of Gabriel et al,
Science 2002 [76]. 95% confidence bounds on D' were
generated and each comparison was called "strong LD",
"inconclusive" or "strong recombination". A block was
created if 95% of informative comparisons were "strong
LD". To identify a set of htSNPs for each gene, we used the
Haploview's tagger feature with the following default set-
tings: pairwise tagging only, r2 threshold 0.8 and LOD
threshold for multi-marker tests 3.0. Of note, htSNPs are
selected on a block-by-block basis; therefore, the end set
of htSNPs is not necessarily the most parsimonious one
for the entire data set, but is more likely to capture varia-
tion in a new, larger data set that was not observed in the
initial data set. Non-synonymous SNPs and SECIS region
SNPs with a minimum rare allele frequency of ≥0.05 were
force included as tagged SNPs.
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Additional File 1
Genotype Frequencies and Hardy-Weinberg Equilibrium (HWE) Cal-
culations for Single Nucleotide Polymorphisms (SNPs) at the GPX1 
Locus. Genotype frequencies and HWE calculations are provided for each 
of the 4 ethnic subpopulations, AA (n = 24), CA (n = 31), HI (n = 23), 
and PR (n = 24; n = 23 for GPX1). RS# refers to the SNPs reference clus-
ter ID, a unique SNP ID assigned by dbSNP[77]. Genotype data for iden-
tified SNPs have been made available through the SNP500 Cancer 
database. Where RS# are not yet assigned, the SNP500 Cancer ID# has 
been provided [63]. Location refers to SNP position relative to the ATG, 
Stop codon, or Intron/Exon position mapped to the provided genomic ref-
erence sequences. Similarly, the Prettybase ID# provides the location of 
each nucleotide variant/SNP, but refers to the nucleotide sequence posi-
tion relative to the start of the genomic reference sequence. GPX1 Geno-
type Frequencies. Genotype frequencies, RS#, SNP location and Hardy-
Weinberg equilibrium data is provided for all GPX1 SNPs in this file.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2156-7-56-S1.pdf]
Additional File 2
Genotype Frequencies and Hardy-Weinberg Equilibrium (HWE) Cal-
culations for Single Nucleotide Polymorphisms (SNPs) at the GPX2 
Locus. Genotype frequencies and HWE calculations are provided for each 
of the 4 ethnic subpopulations, AA (n = 24), CA (n = 31), HI (n = 23), 
and PR (n = 24; n = 23 for GPX1). RS# refers to the SNPs reference clus-
ter ID, a unique SNP ID assigned by dbSNP[77]. Genotype data for iden-
tified SNPs have been made available through the SNP500 Cancer 
database. Where RS# are not yet assigned, the SNP500 Cancer ID# has 
been provided [63]. Location refers to SNP position relative to the ATG, 
Stop codon, or Intron/Exon position mapped to the provided genomic ref-
erence sequences. Similarly, the Prettybase ID# provides the location of 
each nucleotide variant/SNP, but refers to the nucleotide sequence posi-
tion relative to the start of the genomic reference sequence. GPX2 Geno-
type Frequencies. Genotype frequencies, RS#, SNP location and Hardy-
Weinberg equilibrium data is provided for all GPX2 SNPs in this file.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2156-7-56-S2.pdf]BMC Genetics 2006, 7:56 http://www.biomedcentral.com/1471-2156/7/56
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Additional File 3
Genotype Frequencies and Hardy-Weinberg Equilibrium (HWE) Cal-
culations for Single Nucleotide Polymorphisms (SNPs) at the GPX3 
Locus. Genotype frequencies and HWE calculations are provided for each 
of the 4 ethnic subpopulations, AA (n = 24), CA (n = 31), HI (n = 23), 
and PR (n = 24; n = 23 for GPX1). RS# refers to the SNPs reference clus-
ter ID, a unique SNP ID assigned by dbSNP[77]. Genotype data for iden-
tified SNPs have been made available through the SNP500 Cancer 
database. Where RS# are not yet assigned, the SNP500 Cancer ID# has 
been provided [63]. Location refers to SNP position relative to the ATG, 
Stop codon, or Intron/Exon position mapped to the provided genomic ref-
erence sequences. Similarly, the Prettybase ID# provides the location of 
each nucleotide variant/SNP, but refers to the nucleotide sequence posi-
tion relative to the start of the genomic reference sequence. GPX3 Geno-
type Frequencies. Genotype frequencies, RS#, SNP location and Hardy-
Weinberg equilibrium data is provided for all GPX3 SNPs in this file.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2156-7-56-S3.pdf]
Additional File 4
Genotype Frequencies and Hardy-Weinberg Equilibrium (HWE) Cal-
culations for Single Nucleotide Polymorphisms (SNPs) at the GPX4 
Locus. Genotype frequencies and HWE calculations are provided for each 
of the 4 ethnic subpopulations, AA (n = 24), CA (n = 31), HI (n = 23), 
and PR (n = 24; n = 23 for GPX1). RS# refers to the SNPs reference clus-
ter ID, a unique SNP ID assigned by dbSNP[77]. Genotype data for iden-
tified SNPs have been made available through the SNP500 Cancer 
database. Where RS# are not yet assigned, the SNP500 Cancer ID# has 
been provided [63]. Location refers to SNP position relative to the ATG, 
Stop codon, or Intron/Exon position mapped to the provided genomic ref-
erence sequences. Similarly, the Prettybase ID# provides the location of 
each nucleotide variant/SNP, but refers to the nucleotide sequence posi-
tion relative to the start of the genomic reference sequence. GPX4 Geno-
type Frequencies. Genotype frequencies, RS#, SNP location and Hardy-
Weinberg equilibrium data is provided for all GPX4 SNPs in this file.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2156-7-56-S4.pdf]
Additional File 5
Genotype Frequencies and Hardy-Weinberg Equilibrium (HWE) Cal-
culations for Single Nucleotide Polymorphisms (SNPs) at the SEPP1 
Locus. Genotype frequencies and HWE calculations are provided for each 
of the 4 ethnic subpopulations, AA (n = 24), CA (n = 31), HI (n = 23), 
and PR (n = 24; n = 23 for GPX1). RS# refers to the SNPs reference clus-
ter ID, a unique SNP ID assigned by dbSNP[77]. Genotype data for iden-
tified SNPs have been made available through the SNP500 Cancer 
database. Where RS# are not yet assigned, the SNP500 Cancer ID# has 
been provided [63]. Location refers to SNP position relative to the ATG, 
Stop codon, or Intron/Exon position mapped to the provided genomic ref-
erence sequences. Similarly, the Prettybase ID# provides the location of 
each nucleotide variant/SNP, but refers to the nucleotide sequence posi-
tion relative to the start of the genomic reference sequence. SEPP1 Geno-
type Frequencies. Genotype frequencies, RS#, SNP location and Hardy-
Weinberg equilibrium data is provided for all SEPP1 SNPs in this file.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2156-7-56-S5.pdf]
Additional File 6
Genotype Frequencies and Hardy-Weinberg Equilibrium (HWE) Calcula-
tions for Single Nucleotide Polymorphisms (SNPs) at the TXNRD1 Locus. 
Genotype frequencies and HWE calculations are provided for each of the 4 eth-
nic subpopulations, AA (n = 24), CA (n = 31), HI (n = 23), and PR (n = 24; 
n = 23 for GPX1). RS# refers to the SNPs reference cluster ID, a unique SNP 
ID assigned by dbSNP[77]. Genotype data for identified SNPs have been 
made available through the SNP500 Cancer database. Where RS# are not yet 
assigned, the SNP500 Cancer ID# has been provided [63]. Location refers to 
SNP position relative to the ATG, Stop codon, or Intron/Exon position mapped 
to the provided genomic reference sequences. Similarly, the Prettybase ID# pro-
vides the location of each nucleotide variant/SNP, but refers to the nucleotide 
sequence position relative to the start of the genomic reference sequence. 
TXNRD1 Genotype Frequencies. Genotype frequencies, RS#, SNP location 
and Hardy-Weinberg equilibrium data is provided for all TXNRD1 SNPs in 
this file.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2156-
7-56-S6.pdf]
Additional File 7
Most Probable PHASED Haplotypes at the GPX1 Locus Determined Using 
Only Those SNPs With a Minimum Rare Allele Frequency of ≥ 0.05. Hap-
lotype frequencies are provided for the combined SNP500 DNA population (n 
= 102), and for each of the 4 ethnic subpopulations, AA (n = 24), CA (n = 
31), HI (n = 23), and PR (n = 24; n = 23 for GPX1). RS# refers to the SNPs 
reference cluster ID, a unique SNP ID assigned by dbSNP[77]. Location refers 
to SNP position relative to the ATG, Stop codon, or Intron/Exon position 
mapped to the provided genomic reference sequences. Similarly, the Prettybase 
ID# provides the location of each nucleotide variant/SNP, but refers to the 
nucleotide sequence position relative to the start of the genomic reference 
sequence. For convenience, we have identified a possible subset of SNPs for 
each gene that are most likely to capture the full variation at the locus in a new, 
larger data set. These so called haplotype tagged SNPs (htSNPs) are indicated 
by the word Yes. For reference purposes, an imputed Chimp haplotype was 
determined by aligning the human locus of interest to the Chimp genome using 
the Chimp BLAT Search program at the UCSC Genome Bioinformatics Site. 
GPX1 Haplotype Frequencies. The software program PHASE was used to 
define haplotypes for the GPX1 locus. Haplotype frequencies for each ethnic 
population, SNP locations, RS#, and htSNP data are provided.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2156-
7-56-S7.pdf]
Additional File 8
Most Probable PHASED Haplotypes at the GPX2 Locus Determined Using 
Only Those SNPs With a Minimum Rare Allele Frequency of ≥ 0.05. Hap-
lotype frequencies are provided for the combined SNP500 DNA population (n 
= 102), and for each of the 4 ethnic subpopulations, AA (n = 24), CA (n = 
31), HI (n = 23), and PR (n = 24; n = 23 for GPX1). RS# refers to the SNPs 
reference cluster ID, a unique SNP ID assigned by dbSNP[77]. Location refers 
to SNP position relative to the ATG, Stop codon, or Intron/Exon position 
mapped to the provided genomic reference sequences. Similarly, the Prettybase 
ID# provides the location of each nucleotide variant/SNP, but refers to the 
nucleotide sequence position relative to the start of the genomic reference 
sequence. For convenience, we have identified a possible subset of SNPs for 
each gene that are most likely to capture the full variation at the locus in a new, 
larger data set. These so called haplotype tagged SNPs (htSNPs) are indicated 
by the word Yes. For reference purposes, an imputed Chimp haplotype was 
determined by aligning the human locus of interest to the Chimp genome using 
the Chimp BLAT Search program at the UCSC Genome Bioinformatics Site. 
GPX2 Haplotype Frequencies. The software program PHASE was used to 
define haplotypes for the GPX2 locus. Haplotype frequencies for each ethnic 
population, SNP locations, RS#, and htSNP data are provided.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2156-
7-56-S8.pdf]BMC Genetics 2006, 7:56 http://www.biomedcentral.com/1471-2156/7/56
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Additional File 9
Most Probable PHASED Haplotypes at the GPX3 Locus Determined 
Using Only Those SNPs With a Minimum Rare Allele Frequency of ≥ 
0.05. Haplotype frequencies are provided for the combined SNP500 DNA 
population (n = 102), and for each of the 4 ethnic subpopulations, AA (n 
= 24), CA (n = 31), HI (n = 23), and PR (n = 24; n = 23 for GPX1). 
RS# refers to the SNPs reference cluster ID, a unique SNP ID assigned by 
dbSNP[77]. Location refers to SNP position relative to the ATG, Stop 
codon, or Intron/Exon position mapped to the provided genomic reference 
sequences. Similarly, the Prettybase ID# provides the location of each 
nucleotide variant/SNP, but refers to the nucleotide sequence position rel-
ative to the start of the genomic reference sequence. For convenience, we 
have identified a possible subset of SNPs for each gene that are most likely 
to capture the full variation at the locus in a new, larger data set. These 
so called haplotype tagged SNPs (htSNPs) are indicated by the word Yes. 
For reference purposes, an imputed Chimp haplotype was determined by 
aligning the human locus of interest to the Chimp genome using the 
Chimp BLAT Search program at the UCSC Genome Bioinformatics Site. 
GPX3 Haplotype Frequencies. The software program PHASE was used to 
define haplotypes for the GPX3 locus. Haplotype frequencies for each eth-
nic population, SNP locations, RS#, and htSNP data are provided.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2156-7-56-S9.pdf]
Additional File 10
Most Probable PHASED Haplotypes at the GPX4 Locus Determined 
Using Only Those SNPs With a Minimum Rare Allele Frequency of ≥ 
0.05. Haplotype frequencies are provided for the combined SNP500 DNA 
population (n = 102), and for each of the 4 ethnic subpopulations, AA (n 
= 24), CA (n = 31), HI (n = 23), and PR (n = 24; n = 23 for GPX1). 
RS# refers to the SNPs reference cluster ID, a unique SNP ID assigned by 
dbSNP[77]. Location refers to SNP position relative to the ATG, Stop 
codon, or Intron/Exon position mapped to the provided genomic reference 
sequences. Similarly, the Prettybase ID# provides the location of each 
nucleotide variant/SNP, but refers to the nucleotide sequence position rel-
ative to the start of the genomic reference sequence. For convenience, we 
have identified a possible subset of SNPs for each gene that are most likely 
to capture the full variation at the locus in a new, larger data set. These 
so called haplotype tagged SNPs (htSNPs) are indicated by the word Yes. 
For reference purposes, an imputed Chimp haplotype was determined by 
aligning the human locus of interest to the Chimp genome using the 
Chimp BLAT Search program at the UCSC Genome Bioinformatics Site. 
GPX4 Haplotype Frequencies. The software program PHASE was used to 
define haplotypes for the GPX4 locus. Haplotype frequencies for each eth-
nic population, SNP locations, RS#, and htSNP data are provided.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2156-7-56-S10.pdf]
Additional File 11
Most Probable PHASED Haplotypes at the SEPP1 Locus Determined 
Using Only Those SNPs With a Minimum Rare Allele Frequency of ≥ 
0.05. Haplotype frequencies are provided for the combined SNP500 DNA 
population (n = 102), and for each of the 4 ethnic subpopulations, AA (n 
= 24), CA (n = 31), HI (n = 23), and PR (n = 24; n = 23 for GPX1). 
RS# refers to the SNPs reference cluster ID, a unique SNP ID assigned by 
dbSNP[77]. Location refers to SNP position relative to the ATG, Stop 
codon, or Intron/Exon position mapped to the provided genomic reference 
sequences. Similarly, the Prettybase ID# provides the location of each 
nucleotide variant/SNP, but refers to the nucleotide sequence position rel-
ative to the start of the genomic reference sequence. For convenience, we 
have identified a possible subset of SNPs for each gene that are most likely 
to capture the full variation at the locus in a new, larger data set. These 
so called haplotype tagged SNPs (htSNPs) are indicated by the word Yes. 
For reference purposes, an imputed Chimp haplotype was determined by 
aligning the human locus of interest to the Chimp genome using the 
Chimp BLAT Search program at the UCSC Genome Bioinformatics Site. 
SEPP1 Haplotype Frequencies. The software program PHASE was used to 
define haplotypes for the SEPP1 locus. Haplotype frequencies for each eth-
nic population, SNP locations, RS#, and htSNP data are provided.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2156-7-56-S11.pdf]
Additional File 12
Most Probable PHASED Haplotypes at the TXNRD1 Locus Deter-
mined Using Only Those SNPs With a Minimum Rare Allele Fre-
quency of ≥ 0.05. Haplotype frequencies are provided for the combined 
SNP500 DNA population (n = 102), and for each of the 4 ethnic sub-
populations, AA (n = 24), CA (n = 31), HI (n = 23), and PR (n = 24; 
n = 23 for GPX1). RS# refers to the SNPs reference cluster ID, a unique 
SNP ID assigned by dbSNP[77]. Location refers to SNP position relative 
to the ATG, Stop codon, or Intron/Exon position mapped to the provided 
genomic reference sequences. Similarly, the Prettybase ID# provides the 
location of each nucleotide variant/SNP, but refers to the nucleotide 
sequence position relative to the start of the genomic reference sequence. 
For convenience, we have identified a possible subset of SNPs for each 
gene that are most likely to capture the full variation at the locus in a new, 
larger data set. These so called haplotype tagged SNPs (htSNPs) are indi-
cated by the word Yes. For reference purposes, an imputed Chimp haplo-
type was determined by aligning the human locus of interest to the Chimp 
genome using the Chimp BLAT Search program at the UCSC Genome 
Bioinformatics Site. TXNRD1 Haplotype Frequencies. The software pro-
gram PHASE was used to define haplotypes for the TXNRD1 locus. Hap-
lotype frequencies for each ethnic population, SNP locations, RS#, and 
htSNP data are provided.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2156-7-56-S12.pdf]BMC Genetics 2006, 7:56 http://www.biomedcentral.com/1471-2156/7/56
Page 18 of 20
(page number not for citation purposes)
Additional File 13
Estimates for linkage disequilibrium (LD) and location of major hap-
lotype blocks across 6 selenoprotein loci, stratified by ethnic subpopu-
lation. Pair wise plots (D') across 6 selenoprotein loci based on genotype 
data obtained from re-sequencing DNA samples from individuals of AA 
(n = 24), CA (n = 31), HI (n = 23) and PR (n = 24; n = 23 for 
GPX1)heritage from the SNP500 DNA population. Re-sequenced genes 
include a) GPX1, b) GPX2, c) GPX3, d) GPX4, e) SEPP1, and f) 
TXNRD1. SNP identifiers are indicated on the abscissas. Numbers within 
cells correspond to LD values (D'). The LD color scheme is stratified 
according to the logarithm of the odds (LOD) score and D': LOD <2 
(white for D'<1 and blue for D' = 1) or LOD >2 (shades of pink/red for 
D'<1 and bright red for D' = 1). Haplotype blocks were created using the 
algorithm of Gabriel et al, Science 2002 [76]. 95% confidence bounds on 
D' were generated and each comparison was called "strong LD", "incon-
clusive" or "strong recombination". A block was created if 95% of inform-
ative comparisons were "strong LD". LD Plots For Ethnic Subpopulations. 
Estimation of linkage disequilibrium (D') and the location of major hap-
lotype blocks across each of the six selenoprotein loci is provided; the data 
in this file is stratified by ethnic subpopulation.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2156-7-56-S13.pdf]
Additional File 14
PCR Primer Pairs. This file provides the name, location and sequence for 
PCR primers used in the resequencing project.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2156-7-56-S14.txt]
Additional File 15
GPX1 Prettybase File. This file is in prettybase format and provides SNP 
location in the reference sequence, SNP500 sample ID number, and gen-
otype calls for each identified SNP at the GPX1 locus.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2156-7-56-S15.txt]
Additional File 16
GPX2 Prettybase File. This file is in prettybase format and provides SNP 
location in the reference sequence, SNP500 sample ID number, and gen-
otype calls for each identified SNP at the GPX2 locus.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2156-7-56-S16.txt]
Additional File 17
GPX3 Prettybase File. This file is in prettybase format and provides SNP 
location in the reference sequence, SNP500 sample ID number, and gen-
otype calls for each identified SNP at the GPX3 locus.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2156-7-56-S17.txt]
Additional File 18
GPX4 Prettybase File. This file is in prettybase format and provides SNP 
location in the reference sequence, SNP500 sample ID number, and gen-
otype calls for each identified SNP at the GPX4 locus.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2156-7-56-S18.txt]
Additional File 19
SEPP1 Prettybase File. This file is in prettybase format and provides SNP 
location in the reference sequence, SNP500 sample ID number, and gen-
otype calls for each identified SNP at the SEPP1 locus.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2156-7-56-S19.txt]
Additional File 20
TXNRD1 Prettybase File. This file is in prettybase format and provides 
SNP location in the reference sequence, SNP500 sample ID number, and 
genotype calls for each identified SNP at the TXNRD1 locus.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2156-7-56-S20.txt]
Additional File 21
Regions Covered in Resequencing. This file provides the information on 
the regions of the reference sequence for which we were able to get good 
quality sequence data, allowing identification of gaps in sequence coverage 
or regions that could not be resequenced.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2156-7-56-S21.txt]
Additional File 22
GPX1 Genomic Sequence. This file provides the chromosomal location 
and genomic DNA sequence for GPX1 and is the reference used map the 
location of SNPs in the prettybase file and PCR primer pair file.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2156-7-56-S22.txt]
Additional File 23
GPX2 Genomic Sequence. This file provides the chromosomal location 
and genomic DNA sequence for GPX2 and is the reference used map the 
location of SNPs in the prettybase file and PCR primer pair file.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2156-7-56-S23.txt]
Additional File 24
GPX3 Genomic Sequence. This file provides the chromosomal location 
and genomic DNA sequence for GPX3 and is the reference used map the 
location of SNPs in the prettybase file and PCR primer pair file.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2156-7-56-S24.txt]
Additional File 25
GPX4 Genomic Sequence. This file provides the chromosomal location and 
genomic DNA sequence for GPX4 and is the reference used map the location 
of SNPs in the prettybase file and PCR primer pair file.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2156-7-56-S25.txt]
Additional File 26
SEPP1 Genomic Sequence. This file provides the chromosomal location and 
genomic DNA sequence for SEPP1 and is the reference used map the location 
of SNPs in the prettybase file and PCR primer pair file.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2156-
7-56-S26.txt]BMC Genetics 2006, 7:56 http://www.biomedcentral.com/1471-2156/7/56
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